✦ LIBER ✦

Reduction of the number of mice used for potency testing of human and animal rabies vaccines

✍ Scribed by L. Bruckner; M. Palatini; M. Ackermann; H. K. Müller; U. Kihm

Book ID: 105405464
Publisher: Springer
Year: 1988
Tongue: English
Weight: 481 KB
Volume: 44
Category: Article
ISSN: 1420-682X
DOI: 10.1007/bf01941183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Animal Models of Human Parasitic Disease

Animal Models of Human Parasitic Diseases and the Testing of Vaccines

✍ Mitchell, GF 📂 Article 📅 1987 🏛 Nature Publishing Group 🌐 English ⚖ 357 KB

The use of immunosome technology for vac

The use of immunosome technology for vaccines against rabies and other viral diseases

✍ P Sureau; P. Perrin 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 392 KB

Subunit viral vaccines present several advantages. They are free of nucleic acids (of viral and/or cellular origin) and proteins of cellular and/or serum origin; they contain only the relevant antigen. For rabies virus, the antigen which induces the virus-neutralizing antibody (VNAb) is the glycopr

Use of the caprinised strain of rinderpe

Use of the caprinised strain of rinderpest virus for potency testing an attenuated cell culture rinderpest vaccine

✍ F. Guillemin; P. Jouvenet; M. Mosienyane; M. Mannathoko 📂 Article 📅 1988 🏛 Springer Netherlands 🌐 English ⚖ 377 KB

Nucleotide sequence of the nucleoprotein

Nucleotide sequence of the nucleoprotein gene of the RC·HL strain of rabies virus, a seed strain used for animal vaccine production in Japan

✍ Hideo Goto; Nobuyuki Minamoto; Hiroshi Ito; Makoto Sugiyama; Toshio Kinjo; Kazua 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 666 KB

Tolerance of the human brucellosis vacci

Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis

✍ C. Hadjichristodoulou; P. Voulgaris; L. Toulieres; T. Babalis; S. Manetas; G. Go 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 629 KB

Development and prevalidation of two dif

Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringensβ- and ε-toxoid containing veterinary vaccines

✍ Elvira Ebert; Volker Öppling; Esther Werner; Klaus Cussler 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 753 KB